Honz Pharma actively established a scientific research and innovation system, and took the lead in the establishment of National Post Doctoral Research Institute; choosing children's medication as the main research direction. The company has advanced scientific research equipment and a highly educated R & D personnel team, it also established a long-term cooperative relationshipwith a number of domestic and foreign pharmaceutical and research institution; to promote the innovative development of children's health-care industry.
The company always adhere to the development of targeted research. In order to meet the unique requirement of children’s medicationsuch as good in taste and easy to swallow, the R&D team constantly improve the technology level in taste masking, membrane and pelletizing; to ensure Honz Pharma products’taste and other technical indicators maintain advantage in the same kind of products.
The characteristic technical fields of the company's key development：
Rapid dissolving film technology for oral cavity
Supercritical fluid crystallization granulation technology
In 2015, the total investment of 68 million yuan was launched, and the special anti-virus innovative medicine project for the treatment of hand foot mouth disease in children was developed in cooperation with the Shanghai Institute of Pasteur, Chinese Academy of sciences.
Famous varieties of Chinese medicine — — ZhikeJuhong particles, develop its special usage dosage and indications of children.